XML 84 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies - Prior Period Errors (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Research and Development Expense $ 71,677 $ 69,373 $ 75,484
Accrued Liabilities and Other Liabilities 7,248 12,857  
Effect of Change      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Accrued Liabilities and Other Liabilities (323)    
Overstatement due to clinical trial accrual errors | Effect of Change      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Research and Development Expense   3,600  
Accrued Liabilities and Other Liabilities $ 3,600 $ 3,600